His primary areas of study are Genetics, Cancer research, Gene expression profiling, Gene and Complementary DNA. His is doing research in Prostate cancer, Germline mutation, Mutation, Locus and Missense mutation, both of which are found in Genetics. He is involved in the study of Cancer research that focuses on Melanoma in particular.
His Gene expression profiling study incorporates themes from Cell cycle, Genetic heterogeneity, Motility and Regulation of gene expression. The various areas that Jeffrey M. Trent examines in his Gene study include Cancer and Binimetinib. His Complementary DNA study combines topics from a wide range of disciplines, such as Gene chip analysis, Microarray, DNA microarray, Gene expression and Molecular biology.
His primary areas of investigation include Genetics, Cancer research, Molecular biology, Gene and Cancer. His Cancer research research includes elements of Mutation, Germline mutation, Carcinogenesis and SMARCA4. His Molecular biology study which covers Chromosome microdissection that intersects with Microdissection.
Gene is represented through his Complementary DNA, Gene expression, Gene expression profiling and Genome research. In his study, which falls under the umbrella issue of Complementary DNA, DNA microarray is strongly linked to Microarray. His studies examine the connections between Cancer and genetics, as well as such issues in Bioinformatics, with regards to Genomics.
His primary scientific interests are in Cancer research, Cancer, Internal medicine, SMARCA4 and Oncology. His studies deal with areas such as Exome sequencing, Point mutation, Lung cancer, Small-cell carcinoma and Ovarian cancer as well as Cancer research. Cancer is a subfield of Genetics that Jeffrey M. Trent explores.
His Internal medicine research is multidisciplinary, relying on both Microbiome and Endocrinology. His study in Melanoma is interdisciplinary in nature, drawing from both Mutation, Computational biology and Mutant. Jeffrey M. Trent regularly links together related areas like Molecular biology in his Gene studies.
Jeffrey M. Trent mostly deals with Cancer research, Oncology, Internal medicine, Cancer and Melanoma. His studies in Cancer research integrate themes in fields like Cell, Histone methyltransferase, SMARCA4 and Mutant, Point mutation. His Internal medicine study integrates concerns from other disciplines, such as Exome sequencing and Gene expression profiling.
His Cancer research includes themes of Clinical trial and Bioinformatics. His Melanoma study introduces a deeper knowledge of Genetics. He mostly deals with Germline in his studies of Genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
WAF1, a potential mediator of p53 tumor suppression
Wafik S. El-Deiry;Takashi Tokino;Victor E. Velculescu;Daniel B. Levy.
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Fredrick S. Leach;Nicholas C. Nicolaides;Nickolas Papadopoulos;Bo Liu.
Expression profiling using cdna microarrays
David J Duggan;Michael Bittner;Yidong Chen;Paul Meltzer.
Nature Genetics (1999)
The transcriptional program in the response of human fibroblasts to serum.
Vishwanath R. Iyer;Michael B. Eisen;Douglas T. Ross;Greg Schuler.
Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry
Andrew J. Maniotis;Robert Folberg;Angela Hess;Elisabeth A. Seftor.
American Journal of Pathology (1999)
Gene-Expression Profiles in Hereditary Breast Cancer
I Hedenfalk;D Duggan;Y Chen;M Radmacher.
The New England Journal of Medicine (2001)
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Sarah L. Anzick;Juha Kononen;Robert L. Walker;David O. Azorsa.
Genomic Classification of Cutaneous Melanoma
Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert.
High frequency of BRAF mutations in nevi.
Pamela M. Pollock;Ursula L. Harper;Katherine S. Hansen;Laura M. Yudt.
Nature Genetics (2003)
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
Ashani T. Weeraratna;Yuan Jiang;Galen Hostetter;Kevin Rosenblatt.
Cancer Cell (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: